Therapy Areas
29 May 2026 - South Korean biopharmaceutical company Samsung Bioepis Co Ltd announced on Friday the launch of OPUVIZ (aflibercept) 40 mg/mL solution for injection in a vial across Europe.OPUVIZ, an aflibercept biosimilar referencing Regeneron Pharmac...
29 May 2026 - Clinical-stage oncology therapeutics company Whitehawk Therapeutics Inc (Nasdaq:WHWK) announced on Thursday that its president and CEO, Dave Lennon, PhD, will present at the Jefferies 2026 Global Healthcare Conference in New York City, ...
29 May 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HK:01801) and US-based pharmaceutical company Pfizer Inc (NYSE:PFE), have announced on Thursday that they have entered into a strategic global licensing and collaboration agreeme...
29 May 2026 - Clinical stage biotech company Phanes Therapeutics Inc announced on Thursday the release of updated positive Phase 2 results of spevatamig (PT886) in combination with chemotherapy in frontline (1L) treatment of metastatic pancreatic duc...
28 May 2026 - CellCarta, a Canada-based global CRO laboratory to the biopharmaceutical industry, announced on Wednesday a strategic partnership with Sonic Healthcare USA Inc to launch the first commercial laboratory relationship in CellCarta's L...
28 May 2026 - Chinese biotech company Antengene Corporation Limited (SEHK:6996) announced on Wednesday that, following review by the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA), the company has rec...